| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2683248 | Clinical Nutrition | 2010 | 5 Pages |
Abstract
The liver of patients with stable cirrhosis is able to use butyrate and propionate, most likely preventing increased systemic concentrations. This suggests that prebiotics can be administered safely, but monitoring butyrate levels may be advisable in patients with diminished liver function.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Johanne G. Bloemen, Steven W.M. Olde Damink, Koen Venema, Wim A. Buurman, Rajiv Jalan, Cornelis H.C. Dejong,